Streetbeat News

Products Services

QCOM

The full specifications of the OnePlus Open foldable phone have been leaked a day before its planned launch. The device will feature a 7.82-inch 2K resolution flexi-fluid AMOLED display with a 120Hz refresh rate and will be powered by Qualcomm Inc.’s Snapdragon 8 Gen 2 chipset. The leak could potentially influence consumers’ purchase decisions, impacting the initial sales performance of the device.

Portfolio Pulse from Benzinga Neuro

October 18, 2023 | 9:19 am

IHI

Elon Musk's Neuralink could generate over $220M in revenue from its N1 brain implant for ALS patients by 2030, according to Ark Investment Management analyst Pierce Jamieson. The N1 implant and R1 surgical robot are awaiting FDA approval. The technology could transform medicine and accelerate the link between humans and artificial intelligence, Jamieson said. Neuralink recently received FDA approval to commence its first-in-human clinical trial.

Portfolio Pulse from Shanthi Rexaline

October 18, 2023 | 9:16 am

AAPL

Taiwan Semiconductor Manufacturing Company (TSMC), a key supplier for Apple Inc., is reconsidering the location for its upcoming 1nm chip factory due to opposition from local residents. The company is exploring alternate sites within Taiwan. This comes amidst TSMC's growing confidence in Japan, where it plans to start chip production in 2024. TSMC recently faced a 13.4% on-year drop in September sales, part of a larger trend affecting Apple and its key suppliers.

Portfolio Pulse from Benzinga Neuro

October 18, 2023 | 9:13 am

FXI

NIO

VGK

Chinese electric vehicle (EV) manufacturer Nio is reportedly considering the establishment of a dealer network in Europe to accelerate its sales growth. This move is seen as a strategy to boost EV sales in the region.

Portfolio Pulse from Charles Gross

October 18, 2023 | 8:53 am

SNY

Sanofi has announced that its Tzield Phase 3 study met the primary and key secondary endpoints in Stage 3 Type 1 Diabetes in newly diagnosed children and adolescents. This positive result could potentially lead to a new treatment option for this patient group.

Portfolio Pulse from Charles Gross

October 18, 2023 | 8:52 am

AZN

The National Medical Products Administration of China has approved AstraZeneca's Soliris (eculizumab) for Neuromyelitis Optica Spectrum Disorder in patients with anti-aquaporin-4 antibody positive.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 8:49 am

AAPL

MSFT

SFTBF

OpenAI CEO Sam Altman has denied rumors of working on the 'iPhone of AI', a relief to Apple Inc. Altman confirmed that he, along with former Apple designer Sir Jony Ive and SoftBank's Masayoshi Son, is working on a consumer-centric device, but it will not compete with smartphones. Microsoft, one of the largest shareholders of OpenAI, will also contribute to the project.

Portfolio Pulse from Rounak Jain

October 18, 2023 | 8:00 am

AAPL

Apple Inc. (NASDAQ:AAPL) is facing display issues with its Watch Series 9 and Ultra 2, including flickering screens and pink complications. The company is reportedly working on a fix with the upcoming watchOS 10.1 update. The issues have been reported across all current public versions of watchOS 10. Apple has not yet made a public statement addressing the issue or specifying a release date for the watchOS 10.1 update.

Portfolio Pulse from Ananya Gairola

October 18, 2023 | 7:33 am

GSK

PFE

ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK) and Pfizer (PFE), is set to present 23 abstracts from its HIV treatment and prevention portfolio at the EACS 2023. The presentation will include long-term and real-world data from ViiV Healthcare's portfolio of medicines, including long-acting and 2-drug regimens.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 7:32 am

TSLA

Tesla Inc. (NASDAQ:TSLA) has not released an Autopilot safety data report in a year, leading to concerns about the company's transparency. The company had been publishing a quarterly report on Autopilot safety since 2018, but this practice stopped without explanation. The lack of data makes it difficult to track improvements over time, raising questions about Tesla's commitment to deliver on promises made to new buyers since 2016.

Portfolio Pulse from Benzinga Neuro

October 18, 2023 | 7:27 am